Yakov Pakhomov MD, PhD· @yakov_pakhomov · X·· 12 小时前评分60
正文 · 原文
@adamfeuerstein Fair point on the control arm: for macroscopic stage III, neoadjuvant IO is now the bar (NADINA/S1801). But resected IIB/C and microscopic stage III have no neoadjuvant option — that's where INTerpath-001 matters. OS and subgroups will decide. #ESMO26
热度 0 · 0 赞 · 0 回复 · 0 转发
来源:Yakov Pakhomov MD, PhD · x.com
